## **Core Concept**
The question tests understanding of prostaglandin analogues used in neonatology, specifically for maintaining patency of the ductus arteriosus. Prostaglandin E1 (PGE1) is crucial in certain congenital heart defects.

## **Why the Correct Answer is Right**
Prostaglandin E1 (PGE1), also known as alprostadil, is used to keep the ductus arteriosus patent in neonates with ductal-dependent congenital heart defects, such as transposition of the great vessels. This condition requires the ductus arteriosus to remain open to allow for adequate blood flow and mixing of oxygenated and deoxygenated blood. PGE1 works by relaxing the smooth muscle of the ductus arteriosus, thereby preventing its closure.

## **Why Each Wrong Option is Incorrect**
* **Option A:** Incorrect because although prostaglandins have various effects, the specific use in question is related to PGE1.
* **Option B:** Incorrect as it is not the prostaglandin analogue primarily used for this purpose.
* **Option C:** Incorrect because while prostaglandin analogues have several clinical applications, this is not the one used for keeping the ductus arteriosus patent.
* **Option D:** Incorrect as it refers to another prostaglandin not primarily used for this indication.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that PGE1 (alprostadil) is administered to neonates with certain congenital heart defects to maintain ductal patency until surgical intervention can occur. This is a critical intervention that can be lifesaving.

## **Correct Answer:** .